Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC
NCT02893540
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Capecitabine
Sponsor
Ruijin Hospital